Q3 2025 Management View Alex Vetter, CEO, highlighted record revenue and strong customer and product momentum in the third ...

Find insight on Novo Nordisk, AstraZeneca, Hims & Hers Health and more in the latest Market Talks covering Health Care.

Third Quarter 2025 Financial Highlights - Cash Position : Cash and cash equivalents were $81.3 million as of September 30, 2025, compared to $90.4 million as of June 30, 2025. - Revenue : ...

It is worth noting that, alongside the regular CLA 250 models, Mercedes also sold the CLA 45, which was a 355-horsepower powerhouse that transformed the humble compact into a real handful. They ...

CEO Treace stated, "we are not growing our line the way we anticipated for the year," while also noting case volume growth in ...

TransDigm Group Incorporated , a leading global designer, producer and supplier of highly engineered aircraft components, today reported results for the fourth quarter ended September 30, ...

Get key insights from Stanley Black & Decker’s Q3 2025 earnings call—cost reduction progress, supply chain moves, and margin outlook.

Operator: Ladies and gentlemen, thank you for joining us today. And third quarter 2025 results conference call. At this time, ...

SILGAN ANNOUNCES THIRD QUARTER 2025 RESULTS ...

Helping students to develop math fluency takes more than just flash cards. It requires teaching them how to think about ...

Initial Phase 1 monotherapy data for ERAS-0015 and pan-KRAS inhibitor ERAS-4001 expected in 2026 ...

In addition to the purchase of Class A Common Stock, Imran Mir A also acquired 2,083,334 warrants to purchase Class A Common Stock. In other recent news, Rani Therapeutics Holdings, Inc. has made ...